AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $918K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$918K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $14.61
- 52-wk high
- $17.79
- High
- $14.89
- 52-wk low
- $10.48
- Low
- $14.59
- Prev close
- $14.72
- Mkt cap
- $1.87B
- P/E
- 5.8x
- Volume
- 396.9K
- Fwd P/E
- 15.1x
- Beta
- 0.91
- Div yield
- 3.09%
- P/S
- 2.2x
- P/B
- 0.8x
- Profit margin
- +39.5%
- Op margin
- +47.0%
- ROE
- +16.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CMRE filings
Are insiders buying or selling Costamare Inc (CMRE) stock?
Net selling: insiders sold $918K and bought $0 of CMRE stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. The largest was Zikos, Grigorios (Chief Financial Officer), who sold $918K. The latest filing was on Jul 30, 2026.
Which members of Congress have traded CMRE recently?
None. No member of Congress disclosed a CMRE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CMRE smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
Sells (1)
- ZG
Zikos Grigorios
$918K
sold
How top traders are positioned
No tracked top-trader positions in CMRE right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 6.1% below what analysts expected.
Last report
Jul 27, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.66 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 27, 2026 | $0.62 / $0.66Alpha Vantage | -6.06% miss | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | $0.63 / $0.69Alpha Vantage | -8.70% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 18, 2026 | $0.60 / $0.54Alpha Vantage | +11.11% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | $0.81 / $0.71Alpha Vantage | +14.08% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $0.77 / $0.57Alpha Vantage | +35.09% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $0.61 / $0.52Alpha Vantage | +17.31% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $0.69 / $0.65Alpha Vantage | +6.15% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 1, 2024 | $0.68 / $0.64Alpha Vantage | +6.25% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 3, 2026, in 29 days
Financials
Is the business strong?
Fairly priced and profitable.
- Net margin
- 39.5%
- P/E
- 5.83
- Forward P/E
- 15.06
- Market cap
- $1.9B
Valuation
- P/S2.18
- P/B0.80
- Dividend yield3.1%
Quality
- Operating margin47.0%
- ROE16.0%
- ROA6.7%
Growth
- Beta0.91
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace